How are plastics in health care changing to meet medical industry's needs?

Plastics in the medical industry have had to adapt in recent years, particularly because of the COVID-19 pandemic. In this issue, Plastics News reporter Sarah Kominek uncovers the rapid challenges the industry faces and how companies are adapting. To read the issue in PDF form, visit here. 

Nolato Contour USA is expanding its diagnostics capacity "with caution" as demand for COVID-19-related testing continues to rise. 

Since the manufacturing cells for diagnostics are "highly specialized," Nolato is making sure there's a strong business case for its investments through contracts with its customers. Read more on the expansion here.

Gerresheimer AG, a German manufacturer of primary packaging for medical and pharmaceutical industries, is expanding to meet increasing pharmaceutical and small-batch demand. Read more about the expansions at two plants in Germany here. 

With U.S. government plans to distribute 500 million at-home COVID testing devices, medical device manufacturers, like Lanco Integrated and Emerson, are stepping up production and taking advantage of automation to help fill gaps. Read more about the plans here. 

Amid the ongoing COVID-19 pandemic, medical device designers and manufacturers are finding it's critical to stay flexible to their customers' changing demand in order to get products to market quickly. Read the story here.